<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2199-2-5.anc" start="28994" end="29005" sStart="-1" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="At the time of analysis, 1.5 ml of the transfected cells were &lt;b&gt;transferred&lt;/b&gt; to eppendorf tubes, centrifuged and lysed in 320 ?l of lysis buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4, and 0.1% Triton X-100 at pH7)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2199-2-5.anc" start="25992" end="25997" sStart="null" offset="0" sid="null" wn="4" wnkey="show%2:39:00::" text="However, preliminary evidence suggests that unlike the stimulated CD5 expression in these other studies, the low-level constitutive expression of CD5 on the M12 B cell line is enabled by the same 43 bp regulatory region that we have &lt;b&gt;shown&lt;/b&gt; here is sufficient to induce full constitutive CD5 expression on T cells." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2199-2-5.anc" start="25992" end="25997" sStart="null" offset="0" sid="null" wn="2" wnkey="show%2:31:00::" text="However, preliminary evidence suggests that unlike the stimulated CD5 expression in these other studies, the low-level constitutive expression of CD5 on the M12 B cell line is enabled by the same 43 bp regulatory region that we have &lt;b&gt;shown&lt;/b&gt; here is sufficient to induce full constitutive CD5 expression on T cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-5.anc" start="2991" end="2996" sStart="null" offset="165" sid="r7.serve.v.0569" wn="1" wnkey="serve%2:42:03::" text="Consistent with SH-2 interaction, CD5 cytoplasmic tyrosine residues are phosphorylated by p56 lck kinases upon TCR/CD3 ligation and serve as targets for association with proteins containing SH2 domains in both T and B-1a cells [ 12, 21, 22]." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-5.anc" start="165" end="171" sStart="null" offset="120" sid="r9.level.n.0821" wn="1" wnkey="level%1:07:00::" text="The murine CD5 protein (Ly-1), a 67 kD membrane-associated glycoprotein found on all T cells and at low levels on B-1a cells, a CD5-expressing subset of B lymphocytes [ 1, 2, 3, 4]." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-5.anc" start="6051" end="6056" sStart="null" offset="133" sid="r9.level.n.0349" wn="1" wnkey="level%1:07:00::" text="Results show that the 3 kb fragment induces a large increase in luciferase activity, which we define as the full level of CD5 expression in resting T cells (Figure 1b)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-5.anc" start="4472" end="4478" sStart="null" offset="261" sid="r9.level.n.0935" wn="1" wnkey="level%1:07:00::" text="The presence of the Ets binding site in this regulatory region is particularly interesting because levels of Ets-1, a lymphoid-specific member of the Ets family [ 27, 28], have been shown to closely resemble the mRNA and protein levels observed for CD5 in different T cell subsets [ 29] [ 5, 6]." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-5.anc" start="17424" end="17429" sStart="null" offset="265" sid="r9.level.n.0795" wn="1" wnkey="level%1:07:00::" text="By constructing a deletion series of CD5 promoter constructs using luciferase as the reporter gene, we demonstrate that a 43 bp region between the StuI and HincII sites at -215 to -172 is necessary for normal, resting CD5 expression level in T cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-5.anc" start="14072" end="14077" sStart="null" offset="89" sid="r9.level.n.0783" wn="1" wnkey="level%1:07:00::" text="None of the three mutated sites on the CD5X region had any effect on the basal level of transcription (figure 5b)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-5.anc" start="18742" end="18748" sStart="null" offset="81" sid="r9.level.n.0259" wn="1" wnkey="level%1:07:00::" text="Theses findings are consistent with previous evidence showing that Ets-1 levels in T cell subsets correlate with the expression of CD5 on these subsets (see Introduction to this paper)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-5.anc" start="14309" end="14315" sStart="null" offset="86" sid="r9.level.n.0610" wn="1" wnkey="level%1:07:00::" text="In fact, the luciferase activity was reduced almost to background levels with the Ymut1 mutation." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-5.anc" start="7354" end="7358" sStart="null" offset="38" sid="null" wn="2" wnkey="full%5:00:01:whole:00" text="The Ets binding site is important for full CD5 expression" />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-5.anc" start="26035" end="26039" sStart="null" offset="308" sid="r9.full.j.0769" wn="3" wnkey="full%5:00:00:complete:00" text="However, preliminary evidence suggests that unlike the stimulated CD5 expression in these other studies, the low-level constitutive expression of CD5 on the M12 B cell line is enabled by the same 43 bp regulatory region that we have shown here is sufficient to induce full constitutive CD5 expression on T cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-5.anc" start="8347" end="8351" sStart="null" offset="85" sid="r9.full.j.0749" wn="2" wnkey="full%5:00:01:whole:00" text="In contrast, the mutation in the Ets binding site completely abolished the full induction of transcription and reduced the luciferase activity to the basal level." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-5.anc" start="22832" end="22836" sStart="null" offset="145" sid="r9.full.j.0505" wn="2" wnkey="full%5:00:01:whole:00" text="This region is not necessary for basal CD5 transcription but it affects the overall level of CD5 transcription obtained with the full length 3 Kb promoter." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-5.anc" start="14644" end="14648" sStart="null" offset="81" sid="r9.full.j.0301" wn="2" wnkey="full%5:00:01:whole:00" text="To determine whether either the CD5X or the CD5Y region can affect the full level of transcription controlled by the 43 bp CD5 regulatory promoter, we generated the mutations described above in the CD5X and CD5Y regions in the StuI B reporter construct." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-5.anc" start="7354" end="7358" sStart="null" offset="38" sid="null" wn="3" wnkey="full%5:00:00:complete:00" text="The Ets binding site is important for full CD5 expression" />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-5.anc" start="7354" end="7358" sStart="null" offset="38" sid="null" wn="3" wnkey="full%5:00:00:complete:00" text="The Ets binding site is important for full CD5 expression" />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-5.anc" start="6461" end="6465" sStart="null" offset="344" sid="r9.full.j.0775" wn="2" wnkey="full%5:00:01:whole:00" text="Transfections with constructs containing successive deletions of the 3 kb fragment show that removal of DNA regions upstream of a StuI site (at -215, relative to the CD5 protein initiation methionine codon) does not significantly decrease luciferase expression from the level obtained with the full length fragment." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-5.anc" start="7354" end="7358" sStart="null" offset="38" sid="r9.full.j.0451" wn="7" wnkey="full%5:00:00:high:02" text="The Ets binding site is important for full CD5 expression" />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-5.anc" start="7354" end="7358" sStart="null" offset="38" sid="null" wn="2" wnkey="full%5:00:01:whole:00" text="The Ets binding site is important for full CD5 expression" />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-5.anc" start="7354" end="7358" sStart="null" offset="38" sid="null" wn="3" wnkey="full%5:00:00:complete:00" text="The Ets binding site is important for full CD5 expression" />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-5.anc" start="7354" end="7358" sStart="null" offset="38" sid="null" wn="3" wnkey="full%5:00:00:complete:00" text="The Ets binding site is important for full CD5 expression" />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-5.anc" start="16037" end="16041" sStart="null" offset="21" sid="r9.fold.v.0267" wn="2147483645" wnkey="null" text="Competition with 100-fold excess unlabeled CD5X oligo eliminated complexes 1-3 (figure 6a, lane 3)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-5.anc" start="14913" end="14917" sStart="null" offset="56" sid="r9.fold.v.0192" wn="2147483645" wnkey="null" text="The Xmut2 mutation had a measurable effect (2-fold decrease) on the full level of transcription and the Ymut2 mutation reduced the reporter activity by more than three-fold (figure 5c)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-5.anc" start="4389" end="4395" sStart="null" offset="178" sid="r8.family.n.0530" wn="3" wnkey="family%1:14:04::" text="The presence of the Ets binding site in this regulatory region is particularly interesting because levels of Ets-1, a lymphoid-specific member of the Ets family [ 27, 28], have been shown to closely resemble the mRNA and protein levels observed for CD5 in different T cell subsets [ 29] [ 5, 6]." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-5.anc" start="5200" end="5207" sStart="null" offset="72" sid="r10.control.n.0833" wn="2" wnkey="control%1:24:00::" text="Based on these data, we propose a model for CD5 transcriptional control in resting T cells that includes interaction between CD5X, CD5Y and Ets-1." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-5.anc" start="17609" end="17616" sStart="null" offset="159" sid="r10.control.n.0942" wn="2147483645" wnkey="null" text="Further, we show that this region contains an Ets binding site that regulates CD5 transcription, two previously unrecognized regions that also control CD5 expression, one of which is responsible for controlling basal expression of the promoter." />
  </sentences>
</list>